⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XBIO News
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
accessnewswire.com
XBIO
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
accessnewswire.com
XBIO
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock
accessnewswire.com
XBIO
Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results
accessnewswire.com
XBIO